Thai Nakarin Hospital Public Company (TNH) Fair Value & Analysis
Healthcare · TH · Market cap 5.2B THB
Fair value as of: Jul 14, 2026
From 26 valuation models · updated 27 days ago
Share price −2.6% over the past month.
A solid business, screening 53% undervalued on our models.
What matters now
- The price is below even our cautious bear case (29.37 THB). The market is more pessimistic than our downside scenario.
- Solid quality (62/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (29.37 THB to 60.31 THB) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 14, 2026.
How to read this chart
60‑month range 27.39 THB – 37.21 THB · fair‑value band 29.37 THB – 60.31 THB · the 28.25 THB price screens below the 43.32 THB fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 14, 2026.
Analysis
Thai Nakarin Hospital Public Company (TNH) currently trades at 28.25 THB, while our model-based Fair Value estimate is 43.32 THB, implying the stock looks roughly 53.4% undervalued today. The Quality Score stands at 62/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Thai Nakarin Hospital Public Company generated revenue of 2.7B THB at a net margin of 11.9%. Revenue declined 5.1% year over year. It earns a return on equity of 9.7%. The balance sheet holds a net cash position of 1.3B THB. Fundamentals as of Jul 14, 2026
Our scenario range runs from 29.37 THB (bear case) to 60.31 THB (bull case); at 28.25 THB, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 19% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at 53%, TNH screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: Growth Earnings (42.08 THB) versus Dividend Discount (8.44 THB). Highest evidence: Residual Income (76).
Notify me when TNH reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 14, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 63 · Market factors (momentum, volatility) 42
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Thai Nakarin Hospital Public Company Limited, together with its subsidiaries engages in the hospital business in Thailand.
Full company description
Thai Nakarin Hospital Public Company Limited, together with its subsidiaries engages in the hospital business in Thailand. The company offers medical services in the areas of heart, bone and joint, holistic oncology, hemodialysis, hepato-biliary and pancreas, mental health clinics, and traditional chinese medical clinic, as well as operates dental, check up center, gastrointestinal, skin and laser, urology clinics, lasik center, rehabilitation, breast care, diabetes and endocrinology clinic, eye, emergency, X-ray ,surgery, obstetrics and gynecology ear, nose, and throat, medicine, nursery, pediatrics, brain, and neurology center. It also engages in health establishment and hotel business; mobile checkup and small healthcare services. In addition, the company provides elderly and dependency care. Thai Nakarin Hospital Public Company Limited was founded in 1993 and is head in Bangkok, Thailand.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Thai Nakarin Hospital Public Company reported revenue of 2.8B THB in FY2025 versus 2.0B THB in FY2021, a compound +7.9%/yr. Reported net income was 395M THB in FY2025, compounding +7.7%/yr from FY2021.
of which total revenue +4.8 pp · buybacks/dilution +0.0 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch TNH: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 261 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 14, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare Thai Nakarin Hospital Public Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Thai Nakarin Hospital Public Company (TNH) overvalued or undervalued?
What is the fair value of TNH?
What is the quality score of TNH?
What is the revenue of Thai Nakarin Hospital Public Company (TNH)?
What is the net profit margin of TNH?
Does Thai Nakarin Hospital Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Thai Nakarin Hospital Public Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.